Kendra Adams serves as our Senior Vice President of Communications and Investor Relations. Prior to joining C4 Therapeutics, Kendra served as Vice President, External Communications and Investor Relations at Agios Pharmaceuticals, Inc. from January 2019 to November 2020 and as Senior Director, Investor and Public Relations from November 2015 to December 2018. Kendra has more than 15 years of communications and investor relations experience in the biotechnology sector, previously serving Investor Relations roles of increasing responsibility at ARIAD Pharmaceuticals and Amgen. Earlier in her career, Kendra held a variety of finance and operational roles at KPMG LLP and General Electric Company. Kendra holds a B.A. in Economics from Hamilton College.